| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.005 | 1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |